MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/sla.0000000000002191

Медицинская библиотека · Annals of surgery · 2018

Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.

Triponez Frederic, Sadowski Samira M, Pattou François, Cardot-Bauters Catherine, Mirallié Eric, Le Bras Maëlle, Sebag Frédéric, Niccoli Patricia, Deguelte Sophie, Cadiot Guillaume, Poncet Gilles, Lifante Jean-Christophe, Borson-Chazot Françoise, Chaffanjon Philippe, Chabre Olivier, Menegaux Fabrice, Baudin Eric, Ruszniewski Philippe, Du Boullay Hélène, Goudet Pierre

Клиническое исследованиеСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

To report long-term follow-up of patients with multiple endocrine neoplasia type 1 (MEN1) and nonfunctioning pancreatic neuroendocrine tumors (NF-PET).

BACKGROUND

Pancreaticoduodenal tumors occur in almost all patients with MEN1 and are a major cause of death. The natural history and clinical outcome are poorly defined, and management is still controversial for small NF-PET.

METHODS

Clinical outcome and tumor progression were analyzed in 46 patients with MEN1 with 2 cm or smaller NF-PET who did not have surgery at the time of initial diagnosis. Survival data were analyzed using the Kaplan-Meier method.

RESULTS

Forty-six patients with MEN1 were followed prospectively for 10.7 ± 4.2 (mean ± standard deviation) years. One patient was lost to follow-up and 1 died from a cause unrelated to MEN1. Twenty-eight patients had stable disease and 16 showed significant progression of pancreaticoduodenal involvement, indicated by increase in size or number of tumors, development of a hypersecretion syndrome, need for surgery (7 patients), and death from metastatic NF-PET (1 patient). The mean event-free survival was 13.9 ± 1.1 years after NF-PET diagnosis. At last follow-up, none of the living patients who had undergone surgery or follow-up had evidence of metastases on imaging studies.

CONCLUSIONS

Our study shows that conservative management for patients with MEN1 with NF-PET of 2 cm or smaller is associated with a low risk of disease-specific mortality. The decision to recommend surgery to prevent tumor spread should be balanced with operative mortality and morbidity, and patients should be informed about the risk-benefit ratio of conservative versus aggressive management when the NF-PET represents an intermediate risk.

Для цитирования: Triponez Frederic, Sadowski Samira M, Pattou François, Cardot-Bauters Catherine, Mirallié Eric, Le Bras Maëlle, Sebag Frédéric, Niccoli Patricia, Deguelte Sophie, Cadiot Guillaume, Poncet Gilles, Lifante Jean-Christophe, Borson-Chazot Françoise, Chaffanjon Philippe, Chabre Olivier, Menegaux Fabrice, Baudin Eric, Ruszniewski Philippe, Du Boullay Hélène, Goudet Pierre. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.. Annals of surgery. 2018. DOI: 10.1097/sla.0000000000002191.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.